Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVS - IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO


NVS - IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO

  • Kinnate Biopharma aims to raise $170 million in an IPO.
  • The firm is developing kinase inhibitor-based treatment candidates for various cancers.
  • KNTE has produced promising results in preclinical studies, but is still extremely high risk; the IPO may be more suited to long-term hold institutional investors.

For further details see:

IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO
Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...